Studying Stored Samples From Patients With Localized Prostate Cancer Treated on Clinical Trial NCI-00-C-0154
NCT00535834 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 48
Last updated 2012-03-16
Summary
RATIONALE: Studying samples of blood in the laboratory from patients before and after treatment may help doctors learn more about the effects of the treatment on cells.
PURPOSE: This clinical trial is studying samples collected from patients with localized prostate cancer who received treatment on clinical trial NCI-00-C-0154.
Conditions
Interventions
- PROCEDURE
-
diagnostic procedure
- PROCEDURE
-
molecular diagnostic method
- PROCEDURE
-
protein expression analysis
Sponsors & Collaborators
-
National Cancer Institute (NCI)
collaborator NIH -
National Institutes of Health Clinical Center (CC)
lead NIH
Principal Investigators
-
James Gulley, MD, PhD · National Cancer Institute (NCI)
Eligibility
- Min Age
- 18 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Completion
- 2011-03-31
More Related Trials
-
Surgery in Treating Patients With Prostate Cancer
NCT00002938 ·Status: COMPLETED ·Phase: PHASE2
-
Vaccine Plus Booster Shots in Men With Prostate Cancer Undergoing Treatment With Radical Prostatectomy
NCT02153918 ·Status: COMPLETED ·Phase: PHASE2
-
Vaccine Treatment for Hormone Refractory Prostate Cancer
NCT00105053 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Vaccination Priming and Vaccine Boosting Trial of Allogeneic Human GM-CSF Gene Transduced Irradiated Prostate Cancer Cell Vaccines (GVAX® Vaccine for Prostate Cancer)
NCT00140374 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Vaccine Therapy of Prostate Cancer Patients With Recombinant Soluble Prostate-Specific Membrane Antigen (Rs-PSMA) Plus the Immunological Adjuvant Alhydrogel
NCT00705835 ·Status: COMPLETED ·Phase: PHASE1
-
Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
NCT00005992 ·Status: UNKNOWN ·Phase: PHASE1
-
A Study of JNJ-80038114 in Participants With Advanced Stage Prostate Cancer
NCT05441501 ·Status: COMPLETED ·Phase: PHASE1
-
Vaccine and Antibody Treatment of Prostate Cancer
NCT00113984 ·Status: COMPLETED ·Phase: PHASE1
-
Phase II Study of Adenovirus/PSA Vaccine in Men With Hormone - Refractory Prostate Cancer
NCT00583024 ·Status: COMPLETED ·Phase: PHASE2
-
Phase II Study of Adenovirus/PSA Vaccine in Men With Recurrent Prostate Cancer After Local Therapy APP21
NCT00583752 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase I Feasibility Study of an Intraprostatic PSA-Based Vaccine in Men With Prostate Cancer With Local Failure Following Radiotherapy or Cryotherapy or Clinical Progression on Androgen Deprivation Therapy in the Absence of Local Definitive Therapy
NCT00096551 ·Status: COMPLETED ·Phase: PHASE1
-
Follow-Up Study for Men Diagnosed With Prostate Cancer Through Participation in a Prostate Specific Antigen Screening Program
NCT00035217 ·Status: COMPLETED
-
Clinical Study of PSMA-targeted CAR-T Cells in the Treatment of Castration-resistant Prostate Cancer
NCT05354375 ·Status: RECRUITING ·Phase: PHASE1
-
Prostvac in Patients With Biochemically Recurrent Prostate Cancer
NCT02649439 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Proscavax Vaccine in Patients With Localized Prostate Cancer vs Active Surveillance
NCT03579654 ·Status: UNKNOWN ·Phase: PHASE2
-
Trial of Anti-PSMA Designer T Cells in Advanced Prostate Cancer After Non-Myeloablative Conditioning
NCT00664196 ·Status: SUSPENDED ·Phase: PHASE1
-
Vaccine Therapy in Curative Resected Prostate Cancer Patients
NCT01197625 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Vaccine Therapy Plus Sargramostim and Interleukin-2 Compared With Nilutamide Alone in Treating Patients With Prostate Cancer
NCT00020254 ·Status: COMPLETED ·Phase: PHASE2
-
Prostatic Acid Phosphatase (PAP) Vaccine in Patients With Prostate Cancer
NCT00582140 ·Status: COMPLETED ·Phase: PHASE1
-
Neoantigen DNA Vaccine in Combination With Nivolumab/Ipilimumab and PROSTVAC in Metastatic Hormone-Sensitive Prostate Cancer
NCT03532217 ·Status: COMPLETED ·Phase: PHASE1
-
Trial of Anti-PSMA Designer T Cells in Advanced Prostate Cancer After Non-Myeloablative Conditioning
NCT01929239 ·Status: SUSPENDED ·Phase: PHASE1/PHASE2
-
PSA Antibody Levels in Samples From Patients With Prostate Cancer Treated on Protocol ECOG-E9802
NCT01672905 ·Status: COMPLETED
-
Vaccine Therapy Plus QS21 in Treating Patients With Progressive Prostate Cancer
NCT00003819 ·Status: COMPLETED ·Phase: PHASE1
-
Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
NCT00005947 ·Status: COMPLETED ·Phase: PHASE3
-
Fractionated and Multiple Dose 225Ac-J591 for Progressive mCRPC
NCT04506567 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2